Phase III clinical trial of MN-10-T for primary osteoporosis.

Trial Profile

Phase III clinical trial of MN-10-T for primary osteoporosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 May 2016

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Fracture; Male osteoporosis; Postmenopausal osteoporosis
  • Focus Registrational; Therapeutic Use
  • Acronyms TOWER
  • Sponsors Asahi Kasei
  • Most Recent Events

    • 05 Apr 2014 Results of a subgroup analysis presented at the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    • 08 Oct 2013 Results for subgroups presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
    • 20 Jun 2012 Results published in the Journal of Clinical Endocrinology and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top